BDSI

BioDelivery Sciences International, Inc. Press Releases

$12.56
*  
0.08
0.64%
Get BDSI Alerts
*Delayed - data as of Jul. 24, 2014 12:28 ET  -  Find a broker to begin trading BDSI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BDSI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors
7/22/2014 8:00:00 AM - PR Newswire

Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain
7/7/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences Announces Completion of Patient Enrollment in its Initial Phase 3 Trial of Clonidine Topical Gel for Painful Diabetic Neuropathy
6/26/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences Featured on Bloomberg TV, TheStreet.com and Business News Network
6/11/2014 11:34:00 AM - PR Newswire

BioDelivery Sciences to Present at the William Blair and Wells Fargo Healthcare Conferences
6/10/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence
6/9/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence
6/6/2014 5:19:00 PM - PR Newswire

Technical Coverage on Top Gainers -- Research on Noranda Aluminum Holding, Teekay Tankers, BioDelivery Sciences Intl. and Quality Systems
5/27/2014 6:00:00 AM - PR Newswire

BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2014 Financials
5/8/2014 6:00:00 PM - PR Newswire

BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
5/8/2014 7:00:00 AM - PR Newswire

BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy
5/6/2014 7:00:00 AM - PR Newswire